Success Stories: EB-1A Approved for Research Associate in Pennsylvania in the Field of Immunology

Client’s Testimonial:

 

Thanks! I really appreciate your help in filing this application.
 


On July 25th, 2014, We Received Another EB1-A (Alien of Extraordinary Ability) Approval for a Research Associate in the Field of Immunology (Approval Notice)


General Field: Immunology

Position at the Time of Case Filing: Research Associate

Country of Origin: India

Service Center: Texas Service Center (TSC)

State of Residence at the Time of Filing:  Pennsylvania

Approval Notice Date: July 25, 2014

Processing Time: 5 months

 

 


Case Summary:

In this case, the client that we had the opportunity to work with was a Research Associate from India in the field of Immunology.  He had conducted his research in the highly specialized area of the mechanisms of kidney disease and injury. His work had resulted in 8 peer-reviewed scientific articles; at the time that his case was filed, his publications had been cited at least 191 times by independent and leading researchers from prestigious institutions and organizations around the world, indicating the major significance of his work.  He had also reviewed 23 manuscripts for distinctive, internationally-circulated journals.  His superior level of expertise was confirmed in the following quote from an independent recommender, “[Client’s] research is directly applicable to the development of novel and effective treatments for kidney disease, a fact that impacts not only the field of renal immunology, but influences how medical professionals will treat instances of kidney injury, how pharmaceutical companies will create new drugs, as well as the overall health of those individuals that suffer from kidney injury.” It was our goal to prove that our client qualified for classification as an Alien of Extraordinary Ability given that he sought to remain in the United States to continue work in the area of Immunology, and that his continued research would substantially and prospectively benefit the United States. With the proof and documentation that we provided, his case was approved in 5 months.